Conversely, in a state of obesity, GIP levels are elevated during both fasting and after an oral glucose challenge, whereas GLP-1 levels are unchanged during fasting and reduced in response to an oral glucose challenge [37]. The gene discussed is GIP; the disease is obesity due to melanocortin 4 receptor deficiency.